Shortage of Medicines in the Developing Countries

The shortage of medicines in developing countries is a critical issue that hampers access to essential treatments, exacerbates healthcare disparities, and hinders public health initiatives. This chapter described the causes, consequences, and potential strategies to address medicine shortages in developing countries. It explores factors such as limited resources, weak supply chains, regulatory challenges, and economic constraints that contribute to shortages. The implications include compromised patient care, increased healthcare costs, and health inequities. The recommendations encompass strengthening domestic manufacturing, enhancing supply chain management, regulatory reforms, pricing and reimbursement policies, international collaboration, and health system strengthening. These approaches, coupled with research, advocacy, and community engagement, can lead to improved availability and equitable access to medicines in developing countries.